Discussion Topics:
Transvenous Extraction of Conduction System Pacing Leads: An International Multicenter (TECSPAM) Study
Safety, Efficacy, and Reliability Evaluation of a Novel Small-Diameter Defibrillation Lead: Global LEADR Pivotal Trial Results
Tachycardia Therapy and Endpoint Results of the First Modular, Intra-Body, Communicating, Subcutaneous Defibrillator-Leadless Pacemaker System: MODULAR ATP Interim Cohort
The Lead is a journal review podcast designed to keep listeners up to date and informed on the latest publications and hottest topics in electrophysiology. The Lead’s session at Heart Rhythm 2024 includes three discussions, covering Transvenous Extraction of Conduction System Pacing Leads: An International Multicenter (TECSPAM) study and Safety, Efficacy, and Reliability Evaluation of a Novel Small-Diameter Defibrillation Lead: Global LEADR Pivotal Trial Results from the May 2024 issue of Heart Rhythm Journal, as well as Tachycardia therapy and Endpoint Results of the First Modular, Intra-body, Communicating Subcutaneous Defibrillator-Leadless Pacemaker System: MODULAR ATP Interim Cohort from the May 2024 issue of the New England Journal of Medicine. Join us for a lively and informative discussion!
Hosts: Christopher Cheung, MD, MPH, Danesh Kella, MBBS, FHRS, and Deepthy Varghese, MSN, ACNP, FNP
Guests: Anish K. Amin, MD, FHRS, Mihail G. Chelu, MD, PhD, FHRS, Miguel A. Leal, MD, FHRS, Rajeev Kumar Pathak, MBBS, PhD, FHRS, Christopher Aldo A. Rinaldi, MBBS, MD. FHRS, Emily P. Zeitler, MD, MHS, FHRS
Speaker and Article Information: Download
Topic
- Atrial Fibrillation
- The Lead
Resource Type
- Podcasts
Related Resources
The Lead
Podcasts
The Lead Episode 128: A Discussion of Long-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial Fibrillation: The ALONE-AF Randomized Clinical Trial
December 4, 2025
HRX Next
Podcasts
HRX NeXt Ep. 3 – A Conversation about Understanding AI Bias in Clinical Practice
December 3, 2025
The Lead
Podcasts
The Lead Episode 127 A Discussion of Remote Screening for Asymptomatic Atrial Fibrillation: The AMALFI Randomized Clinical Trial
November 20, 2025